Saturday 17 October 2026 Export AMPH’s income statement to Excel — free account

Amphastar Pharmaceuticals, Inc.

AMPH Healthcare Drug Manufacturers Specialty & Generic

Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.

25.87 0.55 −2.08%

Follow AMPH

Alert me

Market cap: $1.1B
P/E: 14.9×
Fwd P/E: 14.7×
Dividend yield: —
F-score: 6/9
Altman Z: 2.54
Beneish M: −2.57
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	14.84%	12.90%	10.39%	10.30%
Piotroski F-Score Full definition →		5	6	6	5
ROA Full definition →		6.95%	6.12%	4.84%	4.68%
ROIC Full definition →		8.46%	7.88%	6.69%	6.57%
Return on Tangible Assets Full definition →		15.03%	12.44%	10.20%	11.49%
Average Days of Receivables Full definition →		75.13	81.49	79.76	73.74
Free Cash Flow per Share Full definition →		2.39	2.54	2.98	3.50
Free Cash Flow Full definition →		110.85	118.83	135.19	152.89
Capital Expenditures Full definition →		(41.42)	(37.28)	(33.69)	(31.72)
Other line items
Cash ROIC Full definition →		6.66%	7.05%	8.05%	9.14%
Accounts Receivable Turnover Full definition →		4.92	4.82	4.76	5.18
Accounts Payable Turnover Full definition →		2.13	2.38	2.31	1.83
Inventory Turnover Full definition →		2.32	2.20	2.13	2.06
Average Days of Payables Full definition →		190.18	148.83	146.89	240.24
Days of Inventory on Hand Full definition →		185.29	177.46	163.73	171.94
Tax Rate Full definition →		(0.18)	(0.21)	(0.23)	(0.23)
Research and Development Expense of Revenue Full definition →		11.15%	11.92%	12.84%	12.95%
Selling, General and Administrative Expense of Revenue Full definition →		17.48%	18.03%	18.31%	19.08%
Share Based Compensation of Revenue Full definition →		3.69%	3.79%	3.91%	3.95%
Interest Coverage Full definition →		5.93	5.51	4.53	4.37
Operating CF/Net income Full definition →		1.36	1.59	2.13	2.35
Depreciation/Fixed assets Full definition →		0.19	0.19	0.20	0.19
Capex/Depreciation Full definition →		(0.70)	(0.62)	(0.55)	(0.52)
Revenue per Share Full definition →		15.56	15.40	15.90	16.73
Operating CF per Share Full definition →		3.28	3.34	3.73	4.23
Capex per Share Full definition →		(0.89)	(0.80)	(0.74)	(0.73)
Capex to Sales Full definition →		0.06	0.05	0.05	0.04

Show all line items

Columns are period end dates

Stockrow Weekly